25 XP   0   0   10

Moderna Inc
Buy, Hold or Sell?

Let's analyse Moderna Inc together

PenkeI guess you are interested in Moderna Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Moderna Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Moderna Inc

I send you an email if I find something interesting about Moderna Inc.

Quick analysis of Moderna Inc (30 sec.)










What can you expect buying and holding a share of Moderna Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.32
When do you have the money?
1 year
How often do you get paid?
31.0%

What is your share worth?

Current worth
$35.07
Expected worth in 1 year
$22.93
How sure are you?
48.3%

+ What do you gain per year?

Total Gains per Share
$-11.82
Return On Investment
-11.1%

For what price can you sell your share?

Current Price per Share
$106.18
Expected price per share
$97.00 - $115.89
How sure are you?
50%

1. Valuation of Moderna Inc (5 min.)




Live pricePrice per Share (EOD)

$106.18

Intrinsic Value Per Share

$-17.94 - $-26.31

Total Value Per Share

$17.14 - $8.77

2. Growth of Moderna Inc (5 min.)




Is Moderna Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$13.8b$18b-$2.2b-14.3%

How much money is Moderna Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.1b$2b-$3.2b-277.4%
Net Profit Margin-146.9%42.7%--

How much money comes from the company's main activities?

3. Financial Health of Moderna Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#6 / 1010

Most Revenue
#12 / 1010

Most Profit
#1010 / 1010

Most Efficient
#600 / 1010

What can you expect buying and holding a share of Moderna Inc? (5 min.)

Welcome investor! Moderna Inc's management wants to use your money to grow the business. In return you get a share of Moderna Inc.

What can you expect buying and holding a share of Moderna Inc?

First you should know what it really means to hold a share of Moderna Inc. And how you can make/lose money.

Speculation

The Price per Share of Moderna Inc is $106.18. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Moderna Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Moderna Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $35.07. Based on the TTM, the Book Value Change Per Share is $-3.04 per quarter. Based on the YOY, the Book Value Change Per Share is $3.60 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.08 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Moderna Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.550.5%-3.09-2.9%4.994.7%1.631.5%1.051.0%
Usd Book Value Change Per Share-0.07-0.1%-3.04-2.9%3.603.4%1.551.5%1.211.1%
Usd Dividend Per Share0.000.0%0.080.1%0.040.0%0.030.0%0.020.0%
Usd Total Gains Per Share-0.07-0.1%-2.96-2.8%3.643.4%1.591.5%1.231.2%
Usd Price Per Share99.45-119.46-153.25-121.77-84.51-
Price to Earnings Ratio45.26-57.74-8.98-5.47-3.42-
Price-to-Total Gains Ratio-1,459.47--447.70-66.66--105.62--99.98-
Price to Book Ratio2.84-2.95-3.53-7.12-5.04-
Price-to-Total Gains Ratio-1,459.47--447.70-66.66--105.62--99.98-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share106.18
Number of shares9
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.080.03
Usd Book Value Change Per Share-3.041.55
Usd Total Gains Per Share-2.961.59
Gains per Quarter (9 shares)-26.6014.27
Gains per Year (9 shares)-106.4157.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
13-109-11615647
26-219-2222112104
39-328-3283168161
412-437-4345224218
514-546-5406280275
617-656-6467336332
720-765-7528392389
823-874-8589448446
926-984-96410503503
1029-1093-107011559560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%10.02.00.083.3%10.010.00.050.0%11.018.00.037.9%11.018.00.037.9%
Book Value Change Per Share0.04.00.00.0%8.04.00.066.7%10.010.00.050.0%14.014.01.048.3%14.014.01.048.3%
Dividend per Share3.00.01.075.0%5.00.07.041.7%7.00.013.035.0%9.00.020.031.0%9.00.020.031.0%
Total Gains per Share0.04.00.00.0%8.04.00.066.7%10.010.00.050.0%14.014.01.048.3%14.014.01.048.3%

Fundamentals of Moderna Inc

About Moderna Inc

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 15:08:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Moderna Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Moderna Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Moderna Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 7.7% means that $0.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Moderna Inc:

  • The MRQ is 7.7%. The company is making a profit. +1
  • The TTM is -146.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ7.7%TTM-146.9%+154.6%
TTM-146.9%YOY42.7%-189.6%
TTM-146.9%5Y-487.3%+340.5%
5Y-487.3%10Y-393.3%-94.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7%-207.2%+214.9%
TTM-146.9%-216.8%+69.9%
YOY42.7%-282.3%+325.0%
5Y-487.3%-436.8%-50.5%
10Y-393.3%-597.3%+204.0%
1.1.2. Return on Assets

Shows how efficient Moderna Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Moderna Inc to the Biotechnology industry mean.
  • 1.2% Return on Assets means that Moderna Inc generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Moderna Inc:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is -5.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.2%TTM-5.9%+7.0%
TTM-5.9%YOY7.8%-13.7%
TTM-5.9%5Y1.1%-6.9%
5Y1.1%10Y-36.5%+37.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2%-13.3%+14.5%
TTM-5.9%-12.8%+6.9%
YOY7.8%-11.6%+19.4%
5Y1.1%-13.8%+14.9%
10Y-36.5%-15.6%-20.9%
1.1.3. Return on Equity

Shows how efficient Moderna Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Moderna Inc to the Biotechnology industry mean.
  • 1.6% Return on Equity means Moderna Inc generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Moderna Inc:

  • The MRQ is 1.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -8.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.6%TTM-8.3%+9.9%
TTM-8.3%YOY11.8%-20.1%
TTM-8.3%5Y4.2%-12.5%
5Y4.2%10Y-135.3%+139.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6%-16.9%+18.5%
TTM-8.3%-16.1%+7.8%
YOY11.8%-14.9%+26.7%
5Y4.2%-19.3%+23.5%
10Y-135.3%-20.1%-115.2%

1.2. Operating Efficiency of Moderna Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Moderna Inc is operating .

  • Measures how much profit Moderna Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Moderna Inc to the Biotechnology industry mean.
  • An Operating Margin of 3.5% means the company generated $0.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Moderna Inc:

  • The MRQ is 3.5%. The company is operating less efficient.
  • The TTM is -167.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ3.5%TTM-167.2%+170.7%
TTM-167.2%YOY47.2%-214.4%
TTM-167.2%5Y-515.8%+348.6%
5Y-515.8%10Y-415.6%-100.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5%-298.0%+301.5%
TTM-167.2%-238.5%+71.3%
YOY47.2%-288.4%+335.6%
5Y-515.8%-486.2%-29.6%
10Y-415.6%-628.4%+212.8%
1.2.2. Operating Ratio

Measures how efficient Moderna Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.00 means that the operating costs are $1.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Moderna Inc:

  • The MRQ is 0.998. The company is less efficient in keeping operating costs low.
  • The TTM is 2.680. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.998TTM2.680-1.682
TTM2.680YOY0.520+2.160
TTM2.6805Y8.234-5.554
5Y8.23410Y7.396+0.838
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9983.235-2.237
TTM2.6803.310-0.630
YOY0.5203.838-3.318
5Y8.2345.679+2.555
10Y7.3967.823-0.427

1.3. Liquidity of Moderna Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Moderna Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.42 means the company has $3.42 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Moderna Inc:

  • The MRQ is 3.425. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.186. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.425TTM3.186+0.238
TTM3.186YOY2.147+1.039
TTM3.1865Y4.625-1.438
5Y4.62510Y4.419+0.205
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4253.863-0.438
TTM3.1864.169-0.983
YOY2.1475.337-3.190
5Y4.6256.122-1.497
10Y4.4196.434-2.015
1.3.2. Quick Ratio

Measures if Moderna Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Moderna Inc to the Biotechnology industry mean.
  • A Quick Ratio of 5.10 means the company can pay off $5.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Moderna Inc:

  • The MRQ is 5.102. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.256. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.102TTM4.256+0.846
TTM4.256YOY2.594+1.662
TTM4.2565Y6.894-2.638
5Y6.89410Y6.334+0.560
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1023.504+1.598
TTM4.2563.991+0.265
YOY2.5945.371-2.777
5Y6.8946.088+0.806
10Y6.3346.395-0.061

1.4. Solvency of Moderna Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Moderna Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Moderna Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.25 means that Moderna Inc assets are financed with 24.8% credit (debt) and the remaining percentage (100% - 24.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Moderna Inc:

  • The MRQ is 0.248. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.250. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.248TTM0.250-0.002
TTM0.250YOY0.315-0.065
TTM0.2505Y0.339-0.089
5Y0.33910Y0.361-0.022
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2480.339-0.091
TTM0.2500.337-0.087
YOY0.3150.271+0.044
5Y0.3390.368-0.029
10Y0.3610.388-0.027
1.4.2. Debt to Equity Ratio

Measures if Moderna Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Moderna Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 33.0% means that company has $0.33 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Moderna Inc:

  • The MRQ is 0.330. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.336. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.330TTM0.336-0.006
TTM0.336YOY0.466-0.130
TTM0.3365Y0.643-0.307
5Y0.64310Y0.698-0.055
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3300.392-0.062
TTM0.3360.403-0.067
YOY0.4660.335+0.131
5Y0.6430.427+0.216
10Y0.6980.461+0.237

2. Market Valuation of Moderna Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Moderna Inc generates.

  • Above 15 is considered overpriced but always compare Moderna Inc to the Biotechnology industry mean.
  • A PE ratio of 45.26 means the investor is paying $45.26 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Moderna Inc:

  • The EOD is 48.319. Based on the earnings, the company is overpriced. -1
  • The MRQ is 45.257. Based on the earnings, the company is overpriced. -1
  • The TTM is 57.735. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD48.319MRQ45.257+3.063
MRQ45.257TTM57.735-12.479
TTM57.735YOY8.980+48.755
TTM57.7355Y5.467+52.268
5Y5.46710Y3.420+2.046
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD48.319-2.300+50.619
MRQ45.257-2.656+47.913
TTM57.735-2.718+60.453
YOY8.980-4.145+13.125
5Y5.467-6.258+11.725
10Y3.420-6.315+9.735
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Moderna Inc:

  • The EOD is 26.083. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 24.430. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -0.749. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD26.083MRQ24.430+1.653
MRQ24.430TTM-0.749+25.179
TTM-0.749YOY40.559-41.308
TTM-0.7495Y-0.883+0.134
5Y-0.88310Y-1.090+0.208
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD26.083-2.974+29.057
MRQ24.430-3.306+27.736
TTM-0.749-3.508+2.759
YOY40.559-5.613+46.172
5Y-0.883-8.378+7.495
10Y-1.090-8.873+7.783
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Moderna Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.84 means the investor is paying $2.84 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Moderna Inc:

  • The EOD is 3.027. Based on the equity, the company is fair priced.
  • The MRQ is 2.835. Based on the equity, the company is underpriced. +1
  • The TTM is 2.954. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.027MRQ2.835+0.192
MRQ2.835TTM2.954-0.119
TTM2.954YOY3.534-0.580
TTM2.9545Y7.121-4.167
5Y7.12110Y5.043+2.078
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.0271.914+1.113
MRQ2.8352.116+0.719
TTM2.9542.097+0.857
YOY3.5342.881+0.653
5Y7.1213.550+3.571
10Y5.0433.936+1.107
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Moderna Inc.

3.1. Institutions holding Moderna Inc

Institutions are holding 71.818% of the shares of Moderna Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Baillie Gifford & Co Limited.11.9243.5984565452753440.0117
2023-12-31Vanguard Group Inc8.85580.073733907072624862322.5921
2023-12-31BlackRock Inc6.60830.0642253016925623062.2729
2023-12-31State Street Corporation3.81940.0707146237236724474.82
2023-09-30Flagship Ventures Management, Inc.2.524672.47049666038-3220705-24.9924
2023-12-31Goldman Sachs Group Inc2.37760.081391032524999265121.8148
2023-12-31Theleme Partners LLP1.919534.856273494564518446.5507
2023-12-31Wellington Management Company LLP1.88720.1347225579161446028.7725
2023-12-31Geode Capital Management, LLC1.71060.067965494611344522.0959
2023-12-31FMR Inc1.66980.04886393351254977966.3388
2023-12-31Morgan Stanley - Brokerage Accounts1.14630.03854389108-922906-17.3739
2023-12-31Capital World Investors0.94790.06423629389-338342-8.5273
2023-12-31Manufacturers Life Insurance Co0.92530.21043542967-333180-8.5956
2023-12-31NORGES BANK0.91280.06073494874-3393-0.097
2023-12-31Coatue Management LLC0.85491.36513273052-1636526-33.3333
2023-12-31Banque Pictet & Cie SA0.81862.57953134229-9198-0.2926
2023-12-31UBS Asset Mgmt Americas Inc0.77970.1168298513056205823.1961
2023-12-31Northern Trust Corp0.77620.053529719969400.0316
2023-12-31Amvescap Plc.0.75990.06892909609-216419-6.9231
2023-12-31Legal & General Group PLC0.73940.0722283089445912019.3577
Total 51.9578116.095198935399+11579969+5.8%

3.2. Funds holding Moderna Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Performer (AFRIS)12.45770.052447597385475973850
2024-02-29Vanguard Total Stock Mkt Idx Inv2.81720.06410763618-42160-0.3902
2023-12-31Vanguard International Growth Inv2.46472.1302941708100
2024-01-31Scottish Mortgage Ord2.4085.50969200342-2714-0.0295
2024-02-29Vanguard Institutional 500 Index Trust2.16770.07148282150831631.0143
2024-02-29Invesco QQQ Trust1.88090.26087186569198720.2773
2023-12-31Vanguard Health Care Inv1.70691.39736521472159671932.4223
2024-01-31Fidelity 500 Index1.03080.08223938397403051.034
2024-02-29SPDR® S&P 500 ETF Trust1.01720.07143886516244280.6325
2024-02-29Vanguard Mid Cap Index Institutional1.00350.22093834087-10099-0.2627
2024-02-29AF High Growth (AFRIS)0.94690.0497361783836178380
2024-02-29iShares Core S&P 500 ETF0.90330.07133451106104940.305
2024-02-29Vanguard Growth Index Investor0.83480.13243189567282400.8933
2023-12-31Vanguard US Growth Investor0.71770.6814274195600
2023-12-31Capital Group Growth Fnd of Amer Comp0.70220.1072268293200
2023-12-31American Funds Growth Fund of Amer A0.70220.1072268293200
2024-02-29Baillie Gifford US Equity Growth0.70042.9662267619200
2024-02-29iShares Biotechnology ETF0.66233.0692530615-11390-0.4481
2024-02-29Health Care Select Sector SPDR® ETF0.65740.5708251176322400.0893
2024-02-29Vanguard Institutional Index I0.57190.07122185168-8765-0.3995
Total 36.353717.6866138897686+52945556+38.1%

3.3. Insider Transactions

Insiders are holding 9.634% of the shares of Moderna Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-08James M MockSELL705101.93
2024-04-03Noubar AfeyanSELL15000101.68
2024-03-27Noubar AfeyanSELL15000109.06
2024-03-20Noubar AfeyanSELL15000102.39
2024-03-13Noubar AfeyanSELL15000108.54
2024-03-08Shannon Thyme KlingerSELL54499.05
2024-02-29James M MockSELL64794.57
2024-02-29Shannon Thyme KlingerSELL67094.57
2024-02-29Stephen HogeSELL238894.57
2024-01-16Stephen HogeSELL15000103.9
2024-01-08James M MockSELL772109.75
2023-12-27Stephen HogeSELL45000100.01
2023-12-27Stephen HogeSELL45000100.01
2023-12-08Shannon Thyme KlingerSELL56379.09
2023-12-06Arpa GaraySELL56478.34
2023-11-01Noubar AfeyanSELL1000076
2023-10-25Noubar AfeyanSELL1000076.99
2023-10-11Noubar AfeyanSELL15000103.3
2023-10-06James M MockSELL2858102.5
2023-10-04Noubar AfeyanSELL15000102.72

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Moderna Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.068-3.036+4355%3.600-102%1.554-104%1.209-106%
Book Value Per Share--35.07340.264-13%43.473-19%22.731+54%16.244+116%
Current Ratio--3.4253.186+7%2.147+59%4.625-26%4.419-23%
Debt To Asset Ratio--0.2480.250-1%0.315-21%0.339-27%0.361-31%
Debt To Equity Ratio--0.3300.336-2%0.466-29%0.643-49%0.698-53%
Dividend Per Share---0.080-100%0.039-100%0.031-100%0.022-100%
Eps--0.549-3.085+662%4.994-89%1.633-66%1.046-47%
Free Cash Flow Per Share--1.018-2.458+342%2.742-63%1.785-43%1.178-14%
Free Cash Flow To Equity Per Share--0.742-3.335+550%0.671+11%1.366-46%1.041-29%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---26.308--------
Intrinsic Value_10Y_min---17.935--------
Intrinsic Value_1Y_max--8.765--------
Intrinsic Value_1Y_min--8.616--------
Intrinsic Value_3Y_max--17.646--------
Intrinsic Value_3Y_min--17.022--------
Intrinsic Value_5Y_max--16.052--------
Intrinsic Value_5Y_min--15.647--------
Market Cap40654198400.000+3%39282750000.00046887561300.000-16%63675502500.000-38%50437724637.048-22%34986243804.861+12%
Net Profit Margin--0.077-1.469+2004%0.427-82%-4.873+6418%-3.933+5199%
Operating Margin--0.035-1.672+4899%0.472-93%-5.158+14906%-4.156+12028%
Operating Ratio--0.9982.680-63%0.520+92%8.234-88%7.396-87%
Pb Ratio3.027+6%2.8352.954-4%3.534-20%7.121-60%5.043-44%
Pe Ratio48.319+6%45.25757.735-22%8.980+404%5.467+728%3.420+1223%
Price Per Share106.180+6%99.450119.455-17%153.245-35%121.771-18%84.507+18%
Price To Free Cash Flow Ratio26.083+6%24.430-0.749+103%40.559-40%-0.883+104%-1.090+104%
Price To Total Gains Ratio-1558.240-7%-1459.474-447.700-69%66.662-2289%-105.618-93%-99.975-93%
Quick Ratio--5.1024.256+20%2.594+97%6.894-26%6.334-19%
Return On Assets--0.012-0.059+598%0.078-85%0.011+10%-0.365+3200%
Return On Equity--0.016-0.083+629%0.118-87%0.042-63%-1.353+8735%
Total Gains Per Share---0.068-2.956+4238%3.639-102%1.585-104%1.231-106%
Usd Book Value--13854000000.00015780250000.000-12%18043750000.000-23%9261356800.000+50%6607109769.759+110%
Usd Book Value Change Per Share---0.068-3.036+4355%3.600-102%1.554-104%1.209-106%
Usd Book Value Per Share--35.07340.264-13%43.473-19%22.731+54%16.244+116%
Usd Dividend Per Share---0.080-100%0.039-100%0.031-100%0.022-100%
Usd Eps--0.549-3.085+662%4.994-89%1.633-66%1.046-47%
Usd Free Cash Flow--402000000.000-956250000.000+338%1145250000.000-65%778050050.000-48%516228362.517-22%
Usd Free Cash Flow Per Share--1.018-2.458+342%2.742-63%1.785-43%1.178-14%
Usd Free Cash Flow To Equity Per Share--0.742-3.335+550%0.671+11%1.366-46%1.041-29%
Usd Market Cap40654198400.000+3%39282750000.00046887561300.000-16%63675502500.000-38%50437724637.048-22%34986243804.861+12%
Usd Price Per Share106.180+6%99.450119.455-17%153.245-35%121.771-18%84.507+18%
Usd Profit--217000000.000-1178500000.000+643%2090500000.000-90%729466200.000-70%478815586.207-55%
Usd Revenue--2813000000.0001712500000.000+64%4702500000.000-40%2185926300.000+29%1520020000.000+85%
Usd Total Gains Per Share---0.068-2.956+4238%3.639-102%1.585-104%1.231-106%
 EOD+3 -5MRQTTM+25 -10YOY+9 -265Y+12 -2310Y+15 -20

4.2. Fundamental Score

Let's check the fundamental score of Moderna Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1548.319
Price to Book Ratio (EOD)Between0-13.027
Net Profit Margin (MRQ)Greater than00.077
Operating Margin (MRQ)Greater than00.035
Quick Ratio (MRQ)Greater than15.102
Current Ratio (MRQ)Greater than13.425
Debt to Asset Ratio (MRQ)Less than10.248
Debt to Equity Ratio (MRQ)Less than10.330
Return on Equity (MRQ)Greater than0.150.016
Return on Assets (MRQ)Greater than0.050.012
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Moderna Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.931
Ma 20Greater thanMa 50105.000
Ma 50Greater thanMa 100101.794
Ma 100Greater thanMa 20098.746
OpenGreater thanClose107.430
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets18,426,000
Total Liabilities4,572,000
Total Stockholder Equity13,854,000
 As reported
Total Liabilities 4,572,000
Total Stockholder Equity+ 13,854,000
Total Assets = 18,426,000

Assets

Total Assets18,426,000
Total Current Assets10,325,000
Long-term Assets8,101,000
Total Current Assets
Cash And Cash Equivalents 2,907,000
Short-term Investments 5,697,000
Net Receivables 1,081,000
Inventory 202,000
Other Current Assets 88,000
Total Current Assets  (as reported)10,325,000
Total Current Assets  (calculated)9,975,000
+/- 350,000
Long-term Assets
Property Plant Equipment 2,658,000
Goodwill 52,000
Long Term Investments 4,743,000
Intangible Assets 44,000
Long-term Assets Other 523,000
Long-term Assets  (as reported)8,101,000
Long-term Assets  (calculated)8,020,000
+/- 81,000

Liabilities & Shareholders' Equity

Total Current Liabilities3,015,000
Long-term Liabilities1,557,000
Total Stockholder Equity13,854,000
Total Current Liabilities
Short-term Debt 25,000
Accounts payable 520,000
Other Current Liabilities 1,902,000
Total Current Liabilities  (as reported)3,015,000
Total Current Liabilities  (calculated)2,447,000
+/- 568,000
Long-term Liabilities
Capital Lease Obligations 1,243,000
Long-term Liabilities Other 256,000
Long-term Liabilities  (as reported)1,557,000
Long-term Liabilities  (calculated)1,499,000
+/- 58,000
Total Stockholder Equity
Retained Earnings 13,606,000
Accumulated Other Comprehensive Income -123,000
Other Stockholders Equity 371,000
Total Stockholder Equity (as reported)13,854,000
Total Stockholder Equity (calculated)13,854,000
+/-0
Other
Cash and Short Term Investments 8,604,000
Common Stock Shares Outstanding 395,000
Current Deferred Revenue568,000
Liabilities and Stockholders Equity 18,426,000
Net Debt -1,664,000
Net Invested Capital 13,854,000
Net Working Capital 7,310,000
Property Plant and Equipment Gross 3,091,000
Short Long Term Debt Total 1,243,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
1,417,161
6,117
6,632
6,245
1,084,489
1,601,767
1,601,767
1,489,160
1,962,149
1,806,207
1,685,279
1,590,899
1,589,422
2,067,541
3,486,006
4,650,873
7,336,750
12,694,000
16,153,000
20,923,000
24,669,000
27,609,000
26,043,000
26,056,000
25,858,000
24,125,000
21,884,000
19,450,000
18,426,000
18,426,00019,450,00021,884,00024,125,00025,858,00026,056,00026,043,00027,609,00024,669,00020,923,00016,153,00012,694,0007,336,7504,650,8733,486,0062,067,5411,589,4221,590,8991,685,2791,806,2071,962,1491,489,1601,601,7671,601,7671,084,4896,2456,6326,1171,417,161
   > Total Current Assets 
1,087,152
401
402
63
783,223
1,162,894
1,162,894
1,117,947
1,563,006
1,546,583
1,435,378
1,094,466
1,262,987
1,249,936
2,796,744
3,577,211
6,297,879
11,703,000
10,969,000
13,425,000
17,570,000
16,350,000
13,563,000
14,297,000
13,431,000
12,122,000
10,599,000
10,799,000
10,325,000
10,325,00010,799,00010,599,00012,122,00013,431,00014,297,00013,563,00016,350,00017,570,00013,425,00010,969,00011,703,0006,297,8793,577,2112,796,7441,249,9361,262,9871,094,4661,435,3781,546,5831,563,0061,117,9471,162,8941,162,894783,223634024011,087,152
       Cash And Cash Equivalents 
50,080
216
264
9
134,859
140,619
140,619
167,060
658,364
502,934
151,624
173,711
235,876
391,720
1,761,629
1,505,581
2,623,850
5,442,000
5,603,000
5,550,000
6,848,000
5,048,000
2,873,000
3,027,000
3,205,000
3,441,000
3,801,000
2,932,000
2,907,000
2,907,0002,932,0003,801,0003,441,0003,205,0003,027,0002,873,0005,048,0006,848,0005,550,0005,603,0005,442,0002,623,8501,505,5811,761,629391,720235,876173,711151,624502,934658,364167,060140,619140,619134,859926421650,080
       Short-term Investments 
1,008,058
0
0
0
621,170
974,236
974,236
905,143
863,063
605,990
918,722
884,829
867,124
825,981
955,384
1,770,721
1,983,758
2,293,000
2,387,000
3,356,000
3,879,000
5,067,000
5,024,000
5,321,000
6,697,000
5,482,000
4,658,000
4,641,000
5,697,000
5,697,0004,641,0004,658,0005,482,0006,697,0005,321,0005,024,0005,067,0003,879,0003,356,0002,387,0002,293,0001,983,7581,770,721955,384825,981867,124884,829918,722605,990863,063905,143974,236974,236621,1700001,008,058
       Net Receivables 
17,951
0
0
0
16,656
18,878
18,878
11,557
30,583
24,008
17,872
25,164
16,297
18,793
57,850
213,453
1,410,527
3,228,000
2,071,000
3,199,000
3,296,000
3,364,000
2,691,000
2,821,000
1,385,000
1,113,000
232,000
1,866,000
1,081,000
1,081,0001,866,000232,0001,113,0001,385,0002,821,0002,691,0003,364,0003,296,0003,199,0002,071,0003,228,0001,410,527213,45357,85018,79316,29725,16417,87224,00830,58311,55718,87818,87816,65600017,951
       Other Current Assets 
11,063
185
138
55
10,538
831
831
33,356
10,996
7,895
9,200
10,762
9,507
13,442
21,881
87,456
233,217
246,000
38,000
43,000
55,000
36,000
76,000
85,000
1,195,000
6,836,000
1,193,000
873,000
88,000
88,000873,0001,193,0006,836,0001,195,00085,00076,00036,00055,00043,00038,000246,000233,21787,45621,88113,4429,50710,7629,2007,89510,99633,35683183110,5385513818511,063
   > Long-term Assets 
0
0
0
0
301,266
0
0
371,213
399,143
259,624
249,901
496,433
326,435
817,605
689,262
1,073,662
1,038,871
991,000
5,184,000
7,498,000
7,099,000
11,259,000
12,480,000
11,759,000
12,427,000
12,003,000
11,285,000
8,651,000
8,101,000
8,101,0008,651,00011,285,00012,003,00012,427,00011,759,00012,480,00011,259,0007,099,0007,498,0005,184,000991,0001,038,8711,073,662689,262817,605326,435496,433249,901259,624399,143371,21300301,2660000
       Property Plant Equipment 
81,207
0
0
0
139,031
202,458
202,458
206,457
211,977
213,460
208,509
203,688
287,909
302,599
321,985
368,593
387,090
461,000
898,000
960,000
1,383,000
1,473,000
1,446,000
2,132,000
2,139,000
2,135,000
2,410,000
2,717,000
2,658,000
2,658,0002,717,0002,410,0002,135,0002,139,0002,132,0001,446,0001,473,0001,383,000960,000898,000461,000387,090368,593321,985302,599287,909203,688208,509213,460211,977206,457202,458202,458139,03100081,207
       Goodwill 
3,558
3,503
3,503
3,503
3,503
3,503
3,503
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52,000
52,000
52,000
52,000
52,00052,00052,00052,0000000000000000000003,5033,5033,5033,5033,5033,5033,558
       Long Term Investments 
236,569
0
0
0
145,851
221,825
221,825
150,355
172,990
437,659
365,032
279,860
159,987
502,479
354,916
691,969
638,848
468,000
4,207,000
6,442,000
6,843,000
9,171,000
10,162,000
8,655,000
8,318,000
7,442,000
6,105,000
5,273,000
4,743,000
4,743,0005,273,0006,105,0007,442,0008,318,0008,655,00010,162,0009,171,0006,843,0006,442,0004,207,000468,000638,848691,969354,916502,479159,987279,860365,032437,659172,990150,355221,825221,825145,851000236,569
       Intangible Assets 
2,312
2,213
2,727
2,679
2,556
2,433
2,309
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,000
46,000
45,000
44,000
44,00045,00046,00048,0000000000000000000002,3092,4332,5562,6792,7272,2132,312
       Long-term Assets Other 
0
0
0
0
16,384
0
0
14,401
14,176
-391,495
-323,640
12,885
-121,461
12,527
12,361
13,100
12,933
12,000
13,000
15,000
46,000
94,000
87,000
52,000
988,000
1,064,000
1,192,000
661,000
523,000
523,000661,0001,192,0001,064,000988,00052,00087,00094,00046,00015,00013,00012,00012,93313,10012,36112,527-121,46112,885-323,640-391,49514,17614,4010016,3840000
> Total Liabilities 
575,310
2,699
4,159
4,615
459,193
452,915
452,915
412,728
431,908
360,174
346,725
339,092
414,612
426,667
539,121
1,891,075
4,775,375
8,856,000
9,449,000
10,799,000
10,524,000
10,534,000
8,058,000
8,064,000
6,735,000
5,262,000
4,935,000
5,995,000
4,572,000
4,572,0005,995,0004,935,0005,262,0006,735,0008,064,0008,058,00010,534,00010,524,00010,799,0009,449,0008,856,0004,775,3751,891,075539,121426,667414,612339,092346,725360,174431,908412,728452,915452,915459,1934,6154,1592,699575,310
   > Total Current Liabilities 
162,802
2,699
4,159
4,615
191,461
200,022
200,022
186,418
222,803
159,159
161,987
147,842
143,115
134,582
161,647
1,473,561
4,388,808
8,441,000
8,840,000
9,957,000
9,128,000
9,238,000
6,812,000
6,807,000
4,923,000
3,499,000
3,123,000
4,385,000
3,015,000
3,015,0004,385,0003,123,0003,499,0004,923,0006,807,0006,812,0009,238,0009,128,0009,957,0008,840,0008,441,0004,388,8081,473,561161,647134,582143,115147,842161,987159,159222,803186,418200,022200,022191,4614,6154,1592,699162,802
       Short-term Debt 
686
917
1,472
1,499
72,715
2,051
0
45,426
79,073
42,183
44,589
60,079
67,652
55,020
89,204
4,731
97,421
753,000
170,000
240,000
211,000
206,000
159,000
260,000
196,000
181,000
221,000
56,000
25,000
25,00056,000221,000181,000196,000260,000159,000206,000211,000240,000170,000753,00097,4214,73189,20455,02067,65260,07944,58942,18379,07345,42602,05172,7151,4991,472917686
       Short Long Term Debt 
686
917
1,472
1,499
1,906
2,051
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000002,0511,9061,4991,472917686
       Accounts payable 
28,157
619
938
1,028
20,725
27,505
27,505
24,356
31,210
38,509
29,609
11,737
7,090
11,034
18,817
20,521
18,359
8,000
77,000
87,000
302,000
199,000
181,000
330,000
487,000
389,000
310,000
494,000
520,000
520,000494,000310,000389,000487,000330,000181,000199,000302,00087,00077,0008,00018,35920,52118,81711,0347,09011,73729,60938,50931,21024,35627,50527,50520,7251,02893861928,157
       Other Current Liabilities 
134,645
445
451
752
1,282
139,137
139,137
1,227
3,464
4,509
4,388
5,835
5,063
9,686
8,382
213,803
405,835
149,000
1,291,000
1,653,000
2,362,000
3,234,000
2,379,000
2,215,000
2,202,000
1,710,000
1,552,000
2,463,000
1,902,000
1,902,0002,463,0001,552,0001,710,0002,202,0002,215,0002,379,0003,234,0002,362,0001,653,0001,291,000149,000405,835213,8038,3829,6865,0635,8354,3884,5093,4641,227139,137139,1371,282752451445134,645
   > Long-term Liabilities 
0
0
0
0
267,732
0
0
226,310
209,105
201,015
184,738
191,250
271,497
292,085
377,474
417,514
386,567
415,000
609,000
842,000
1,396,000
1,296,000
1,246,000
1,257,000
1,812,000
1,763,000
1,812,000
1,610,000
1,557,000
1,557,0001,610,0001,812,0001,763,0001,812,0001,257,0001,246,0001,296,0001,396,000842,000609,000415,000386,567417,514377,474292,085271,497191,250184,738201,015209,105226,31000267,7320000
       Long term Debt Total 
0
0
0
0
0
0
0
0
33,489
33,384
33,588
33,801
38,689
38,930
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000038,93038,68933,80133,58833,38433,48900000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
33,384
33,588
33,801
132,364
147,849
167,772
212,294
207,295
234,000
603,000
583,000
916,000
947,000
728,000
1,261,000
1,004,000
927,000
947,000
1,272,000
1,243,000
1,243,0001,272,000947,000927,0001,004,0001,261,000728,000947,000916,000583,000603,000234,000207,295212,294167,772147,849132,36433,80133,58833,384000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
213
188
161
138
1,247
1,224
2,183
386,567
2,000
1,000
1,000
1,396,000
91,000
113,000
81,000
135,000
163,000
173,000
172,000
256,000
256,000172,000173,000163,000135,00081,000113,00091,0001,396,0001,0001,0002,000386,5672,1831,2241,247138161188213000000000
> Total Stockholder Equity
841,851
3,419
2,474
1,631
625,296
-551,365
-688,768
1,076,432
1,530,241
1,446,033
1,338,554
1,251,807
1,174,810
1,640,874
2,946,885
2,759,798
2,561,375
3,838,000
6,704,000
10,124,000
14,145,000
17,075,000
17,985,000
17,992,000
19,123,000
18,863,000
16,949,000
13,455,000
13,854,000
13,854,00013,455,00016,949,00018,863,00019,123,00017,992,00017,985,00017,075,00014,145,00010,124,0006,704,0003,838,0002,561,3752,759,7982,946,8851,640,8741,174,8101,251,8071,338,5541,446,0331,530,2411,076,432-688,768-551,365625,2961,6312,4743,419841,851
   Common Stock
6
583
59
60
6
14
14
30
33
33
33
33
34
37
39
40
40
0
0
0
-857,000
0
0
0
0
0
0
0
0
00000000-857,000000404039373433333333301414660595836
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
-1,006,627
-1,111,300
-1,246,354
-1,369,548
-1,500,000
-1,620,684
-1,737,397
-1,971,033
-2,243,518
-1,023,000
1,757,000
5,090,000
9,958,000
13,615,000
15,812,000
16,855,000
18,320,000
18,399,000
17,019,000
0
0
0017,019,00018,399,00018,320,00016,855,00015,812,00013,615,0009,958,0005,090,0001,757,000-1,023,000-2,243,518-1,971,033-1,737,397-1,620,684-1,500,000-1,369,548-1,246,354-1,111,300-1,006,62700000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-1,157
0
0
-922
-1,320
591
2,741
2,830
1,804
-6,127
8,256
4,784
3,004
1,000
16,000
31,000
-24,000
-184,000
-240,000
-351,000
-370,000
-267,000
-263,000
-211,000
-123,000
-123,000-211,000-263,000-267,000-370,000-351,000-240,000-184,000-24,00031,00016,0001,0003,0044,7848,256-6,1271,8042,8302,741591-1,320-92200-1,1570000
   Capital Surplus 
0
0
0
0
0
0
0
0
2,538,155
2,556,709
2,582,134
2,618,492
2,669,426
3,267,648
4,675,987
4,726,007
4,801,849
4,860,000
4,931,000
5,003,000
4,211,000
3,644,000
2,413,000
1,488,000
1,173,000
731,000
193,000
0
0
00193,000731,0001,173,0001,488,0002,413,0003,644,0004,211,0005,003,0004,931,0004,860,0004,801,8494,726,0074,675,9873,267,6482,669,4262,618,4922,582,1342,556,7092,538,15500000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
-403
0
-217
-103
71,679
-2,009
-2,009
1,950,433
2,601,291
2,556,300
2,581,875
2,618,322
2,669,230
3,267,611
4,676,243
4,725,791
4,801,849
4,860,000
4,931,000
5,003,000
5,068,000
3,644,000
2,413,000
1,488,000
1,173,000
731,000
193,000
277,000
371,000
371,000277,000193,000731,0001,173,0001,488,0002,413,0003,644,0005,068,0005,003,0004,931,0004,860,0004,801,8494,725,7914,676,2433,267,6112,669,2302,618,3222,581,8752,556,3002,601,2911,950,433-2,009-2,00971,679-103-2170-403



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,754,000
Cost of Revenue-4,693,000
Gross Profit2,061,0002,061,000
 
Operating Income (+$)
Gross Profit2,061,000
Operating Expense-6,300,000
Operating Income-4,239,000-4,239,000
 
Operating Expense (+$)
Research Development4,845,000
Selling General Administrative1,454,000
Selling And Marketing Expenses0
Operating Expense6,300,0006,299,000
 
Net Interest Income (+$)
Interest Income405,000
Interest Expense-38,000
Other Finance Cost-4,000
Net Interest Income363,000
 
Pretax Income (+$)
Operating Income-4,239,000
Net Interest Income363,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,942,000-4,153,000
EBIT - interestExpense = -3,870,000
-3,942,000
-4,676,000
Interest Expense38,000
Earnings Before Interest and Taxes (EBIT)-3,832,000-3,904,000
Earnings Before Interest and Taxes (EBITDA)-3,211,000
 
After tax Income (+$)
Income Before Tax-3,942,000
Tax Provision-1,109,000
Net Income From Continuing Ops-3,466,000-5,051,000
Net Income-4,714,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses10,993,000
Total Other Income/Expenses Net-86,000-363,000
 

Technical Analysis of Moderna Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Moderna Inc. The general trend of Moderna Inc is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Moderna Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Moderna Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 112.00 < 114.25 < 115.89.

The bearish price targets are: 101.73 > 100.30 > 97.00.

Tweet this
Moderna Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Moderna Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Moderna Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Moderna Inc. The current macd is 0.79755448.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Moderna Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Moderna Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Moderna Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Moderna Inc Daily Moving Average Convergence/Divergence (MACD) ChartModerna Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Moderna Inc. The current adx is 15.22.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Moderna Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Moderna Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Moderna Inc. The current sar is 114.91.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Moderna Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Moderna Inc. The current rsi is 52.93. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Moderna Inc Daily Relative Strength Index (RSI) ChartModerna Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Moderna Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Moderna Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Moderna Inc Daily Stochastic Oscillator ChartModerna Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Moderna Inc. The current cci is 31.51.

Moderna Inc Daily Commodity Channel Index (CCI) ChartModerna Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Moderna Inc. The current cmo is 6.05201407.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Moderna Inc Daily Chande Momentum Oscillator (CMO) ChartModerna Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Moderna Inc. The current willr is -58.52923448.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Moderna Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Moderna Inc Daily Williams %R ChartModerna Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Moderna Inc.

Moderna Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Moderna Inc. The current atr is 4.74291831.

Moderna Inc Daily Average True Range (ATR) ChartModerna Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Moderna Inc. The current obv is 31,310,174.

Moderna Inc Daily On-Balance Volume (OBV) ChartModerna Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Moderna Inc. The current mfi is 53.22.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Moderna Inc Daily Money Flow Index (MFI) ChartModerna Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Moderna Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Moderna Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Moderna Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.931
Ma 20Greater thanMa 50105.000
Ma 50Greater thanMa 100101.794
Ma 100Greater thanMa 20098.746
OpenGreater thanClose107.430
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Moderna Inc with someone you think should read this too:
  • Are you bullish or bearish on Moderna Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Moderna Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Moderna Inc

I send you an email if I find something interesting about Moderna Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Moderna Inc.

Receive notifications about Moderna Inc in your mailbox!